On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.

The recent death of the 48-year-old actor James Van Der Beek is again highlighting how colorectal cancer is increasingly ...

Tolion Health AI, a digital health company developing personalized, preventive, and predictive artificial intelligence (AI) ...

Scientists at Northwell Health's Feinstein Institutes for Medical Research have unveiled a novel drug discovery strategy that transforms a previously identified "detrimental" immune element into a ...

Applications are invited from individuals with a strong academic record who wish to develop a career in primary care research. Applicants must have a first degree in a discipline relevant to primary ...

The broader Miami-Fort Lauderdale-West Palm Beach metro produced $533.7 billion in GDP in 2023, a nearly 9% year-over-year ...

AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company developing novel immune checkpoint enhancers to address the unmet need in immunological and inflammatory diseases, with a ...

HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated ...

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite ...

Researchers from Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago have developed the first device that can continuously track a fetus’s vital signs while still ...

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025.

Momentum behind brain-computer interfaces is growing, but experts say that design innovations are needed to help them survive ...